- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05936775
Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant
April 8, 2024 updated by: Mohamed Hamdy Mahmoud Ismail, October University for Modern Sciences and Arts
Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant Versus Sandblasted Large Thread Acid Etched Implants in Posterior Maxilla. A Randomized Clinical Trial
the purpose of this trial is to evaluate the osseointegration properties of nano-hydroxy apatite coated titanium implants in posterior maxilla.
30 patients will be included in this trial divided into two groups, control and intervention.
Primary and secondary implant stability will be measured
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mohamed Ha Mahmoud Ismail, PhD
- Phone Number: +201002838699
- Email: mmhamdy@msa.edu.eg
Study Locations
-
-
-
Giza, Egypt
- October University for Modern Sciences and Arts faulty of Dentistry
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Patients with missing at least one maxillary posterior tooth
- Patients free from any systemic disease
- Patients who approve to be included in the trial and sign the informed consent
- Patients with no intra-bony defect.
- Adults aged 18 years old and above
Exclusion Criteria:
- Patients who are allergic to titanium
- Heavy smoker patient
- Patients receiving chemotherapy or radiotherapy
- Patients who refused to be included in the trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Nano-hydroxy apatite arm
in this groups patients will receive nano-hydroxy apatite coated titanium implants
|
titanium implants with surface treatment of nano-hydroxy apatite
|
Active Comparator: SLA arm
in this group patients will receive sandblasted large thread acid etched titanium implants
|
titanium implants with SLA surface treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implant stability
Time Frame: immediately post-operative
|
implant stability will be measured by radiofrequency analysis
|
immediately post-operative
|
Implant stability
Time Frame: 4 weeks post-operative
|
implant stability will be measured by radiofrequency analysis
|
4 weeks post-operative
|
Implant stability
Time Frame: 6 weeks post-operative
|
implant stability will be measured by radiofrequency analysis
|
6 weeks post-operative
|
Implant stability
Time Frame: 12 weeks post-operative
|
implant stability will be measured by radiofrequency analysis
|
12 weeks post-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Mohamed H Mahmoud, PhD, october university for modern science and arts faculty of dentistry
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 22, 2023
Primary Completion (Actual)
April 1, 2024
Study Completion (Actual)
April 5, 2024
Study Registration Dates
First Submitted
June 22, 2023
First Submitted That Met QC Criteria
June 29, 2023
First Posted (Actual)
July 10, 2023
Study Record Updates
Last Update Posted (Actual)
April 9, 2024
Last Update Submitted That Met QC Criteria
April 8, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implant Site Reaction
-
National Research Centre, EgyptCompletedImplant Complication | Implant Site ReactionEgypt
-
Cairo UniversityNot yet recruitingDental Implant Failed | Implant Site Reaction
-
Yi ZhouRecruitingImplant Site ReactionChina
-
The Dental Hospital of Zhejiang University School...Active, not recruitingImplant Site ReactionChina
-
Cairo UniversityCompleted
-
Cairo UniversityRecruiting
-
University of Santiago de CompostelaInstitut Straumann AGCompleted
-
Universitat Internacional de CatalunyaCompleted
-
Cairo UniversityUnknownImplant Site ReactionEgypt
-
Cairo UniversityUnknownImplant Site Reaction
Clinical Trials on nano-hydroxy apatite coated titanium implants
-
Cairo UniversityCompletedImmediate Implant With Bone GraftEgypt
-
Nanoker Research S.L.National Research Council, Spain; Horizon 2020 - European Commission; Experior; ICOA Noroeste SLPCompletedPeri-ImplantitisSpain